Avelumab 200mg/10ml solution for infusion vials
NHS hospitals in England used £61,478,554 of indicative cost of Avelumab 200mg/10ml solution for infusion vials in the 12 months to July 2026, about 0.2% of all hospital medicines spend. That is up 0.2% on the previous 12 months.
Indicative cost · 12 months
Quantity (VMP units) · 12 months
Share of hospital medicines spend
Figure 1. Avelumab 200mg/10ml solution for infusion vials: NHS hospital indicative cost by month (£ millions)
Source: NHSBSA Secondary Care Medicines Data, to July 2026
Cost is indicative — actual hospital medicine prices are commercially confidential, so these figures are estimated from list prices. See methodology.
NHS trusts using Avelumab 200mg/10ml solution for infusion vials most
By indicative cost over the 12 months to July 2026.
| NHS trust | Indicative cost (12 months) |
|---|---|
| The Clatterbridge Cancer Centre Nhs Ft | £4,477,440 |
| The Christie Nhs Foundation Trust | £2,562,048 |
| Royal Surrey County Hosp Nhs Found Trust | £2,429,952 |
| United Lincolnshire Hospitals Nhs Trust | £2,075,904 |
| Univ Hpl B/Ham Nhs Foundation Trust | £2,057,472 |
| Oxford University Hospitals Nhs Ft | £2,040,960 |
| Leeds Teaching Hpls Nhs Trust | £1,916,928 |
| Sheffield Teaching Hospitals Nhs Trust | £1,784,064 |
| Southend Univ Hosp Nhs Foundation Trust | £1,747,968 |
| Colchester Hospital University Nhs Ft | £1,675,776 |
The primary-care picture
Avelumab is also dispensed in the community. See the national primary-care prescribing volume, cost and trend on the Avelumab medicine page.